H. E. Lehmann

2.1k total citations
100 papers, 1.5k citations indexed

About

H. E. Lehmann is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, H. E. Lehmann has authored 100 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Psychiatry and Mental health, 14 papers in Pharmacology and 13 papers in Clinical Psychology. Recurrent topics in H. E. Lehmann's work include Schizophrenia research and treatment (16 papers), Treatment of Major Depression (13 papers) and Bipolar Disorder and Treatment (9 papers). H. E. Lehmann is often cited by papers focused on Schizophrenia research and treatment (16 papers), Treatment of Major Depression (13 papers) and Bipolar Disorder and Treatment (9 papers). H. E. Lehmann collaborates with scholars based in Canada, United States and United Kingdom. H. E. Lehmann's co-authors include T. A. Ban, Thomas A. Ban, A.M. Ghadirian, Joannis N. Nestoros, J. Ananth, Hector Warnes, F. Engelsmann, Fred R. Fenton, Stephanie Feldman and William H. Wilson and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Neurology.

In The Last Decade

H. E. Lehmann

92 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. E. Lehmann Canada	22	601	305	223	172	169	100	1.5k
Nathan S. Kline United States	20	639 1.1×	335 1.1×	221 1.0×	148 0.9×	138 0.8×	122	1.7k
Albert A. Kurland United States	23	490 0.8×	224 0.7×	536 2.4×	126 0.7×	83 0.5×	100	1.4k
Brian Davies Australia	22	528 0.9×	528 1.7×	199 0.9×	93 0.5×	179 1.1×	77	1.5k
J. Ananth Canada	20	736 1.2×	262 0.9×	328 1.5×	244 1.4×	159 0.9×	92	1.8k
R R Fieve United States	26	1.1k 1.9×	413 1.4×	456 2.0×	129 0.8×	327 1.9×	63	1.8k
Gilbert Honigfeld United States	17	1.5k 2.5×	197 0.6×	426 1.9×	197 1.1×	110 0.7×	47	2.1k
Robert Barnes United States	19	794 1.3×	373 1.2×	268 1.2×	111 0.6×	159 0.9×	26	1.7k
V.B. Tuason United States	18	571 1.0×	212 0.7×	597 2.7×	99 0.6×	365 2.2×	58	1.5k
J M Perel United States	21	707 1.2×	654 2.1×	406 1.8×	135 0.8×	309 1.8×	39	1.8k
James L. Claghorn United States	21	831 1.4×	506 1.7×	476 2.1×	362 2.1×	355 2.1×	70	1.7k

Countries citing papers authored by H. E. Lehmann

Since Specialization

Citations

This map shows the geographic impact of H. E. Lehmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. E. Lehmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. E. Lehmann more than expected).

Fields of papers citing papers by H. E. Lehmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. E. Lehmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. E. Lehmann. The network helps show where H. E. Lehmann may publish in the future.

Co-authorship network of co-authors of H. E. Lehmann

This figure shows the co-authorship network connecting the top 25 collaborators of H. E. Lehmann. A scholar is included among the top collaborators of H. E. Lehmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. E. Lehmann. H. E. Lehmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nestoros, Joannis N., et al.. (2015). Neuroleptic Drugs and Sexual Function in Schizophrenia. PubMed. 15. 111–130.

Ghadirian, A.M. & H. E. Lehmann. (1993). Environment and Psychopathology. 17 indexed citations

Lehmann, H. E., et al.. (1988). An 11‐year follow‐up study of 110 depressed patients. Acta Psychiatrica Scandinavica. 78(1). 57–65. 59 indexed citations

Badura, Bernhard, et al.. (1988). [Social support and coping with disease--new results from the Oldenburg longitudinal study 4 1/2 years after the first infarction].. PubMed. 38(1). 48–58. 3 indexed citations

Amin, Mohammad, Palwasha Khan, & H. E. Lehmann. (1980). The differential effects of viloxazine and imipramine on performance tests: their relationship to behavioural toxicity.. PubMed. 16(3). 57–8. 8 indexed citations

Lehmann, H. E.. (1979). Problems with ethical aspects of psychotropic drug use. Progress in Neuro-Psychopharmacology. 3(1-3). 271–275. 1 indexed citations

Lehmann, H. E.. (1979). Negative aspects of psychotherapeutic drug treatment. Progress in Neuro-Psychopharmacology. 3(1-3). 223–229. 4 indexed citations

Lehmann, H. E., et al.. (1976). A double-blind comparative clinical trial with maprotiline (Ludiomil) and imipramine in newly-admitted depressed patients.. PubMed. 19(4). 463–8. 6 indexed citations

Pecknold, John C., et al.. (1975). A clinical trial with nomifensin, a new antidepressant drug.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 11(4). 304–8. 10 indexed citations

10.

Lehmann, H. E., et al.. (1972). Nicotinic Acid, Thioridazine, Fluoxymesterone and their Combinations in Hospitalized Geriatric Patients ^{: A Systematic Clinical Study}. Canadian Psychiatric Association Journal. 17(4). 315–320. 4 indexed citations

11.

Ananth, J., T. A. Ban, H. E. Lehmann, & Jean Bennett. (1970). Nicotinic Acid in the Prevention and Treatment of Methionine-Induced Exacerbation of Psychopathology in Schizophrenics. Canadian Psychiatric Association Journal. 15(1). 15–20. 12 indexed citations

12.

Lehmann, H. E., et al.. (1970). A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital.. PubMed. 41(7). 909–16. 11 indexed citations

13.

Silver, Diana, H. E. Lehmann, V. A. Kral, & T. A. Ban. (1968). Selection and Prediction of Therapeutic Responsiveness in Geriatric Patients. Canadian Psychiatric Association Journal. 13(6). 561–563. 4 indexed citations

14.

Lehmann, H. E.. (1967). Empathy and perspective or consensus and automation?. Comprehensive Psychiatry. 8(5). 265–276. 2 indexed citations

15.

Ban, T. A., et al.. (1966). Conditional Reflex Studies in Depression. Canadian Psychiatric Association Journal. 11(1_suppl). 98–104. 6 indexed citations

16.

Lehmann, H. E.. (1963). Additional Notes and Comments. Psychosomatics. 4(5). 294–295. 1 indexed citations

17.

Lehmann, H. E.. (1962). The Phenomena of Depressions. JAMA. 181(3). 275–275. 34 indexed citations

18.

Ban, T. A., et al.. (1961). Observations on the Action of Sernyl — A New Psychotropic Drug. Canadian Psychiatric Association Journal. 6(3). 150–157. 50 indexed citations

19.

Lehmann, H. E., et al.. (1958). The Treatment of Depressive Conditions with Imipramine (G 22355). Canadian Psychiatric Association Journal. 3(4). 155–164. 74 indexed citations

20.

Lehmann, H. E., et al.. (1957). Observations on the Clinical Effects of a new Tranquillizing Agent in Psychotic Conditions. Canadian Psychiatric Association Journal. 2(2). 104–113. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact